| INTRODUCTION
Soft tissue sarcomas (STS) are a heterogeneous group of mesenchymal neoplasms derived from soft tissues. 1 They are reported to represent 15% of all skin and subcutaneous tumours in dogs and 7% in cats. 2 STSs are typically considered locally invasive and of metastatic potential. However, rates of local recurrence and metastasis are variable, making accurate prognostication in individual cases difficult. 1 Various tumour subtypes such as fibrosarcoma, myxosarcoma, liposarcoma, perivascular wall tumour, and peripheral nerve sheath tumour are included in the STS group. 1 A few studies have described a trend that suggest fibrosarcoma and liposarcoma may carry a worse prognosis than other STS subtypes. [3] [4] [5] However, currently, the histological subtype has little bearing on the clinical management of these tumours as more studies are needed to confirm and to measure differences in prognosis among sufficient numbers of tumours of each subtype. 1 In addition, an accurate identification of the STS subtype frequently relies on a large panel of immunohistochemical markers, including those applied to frozen sections, 1 making this practice difficult to be routinely applied in the clinical setting.
Genetic alterations have been showed in STS in human and dogs. 6, 7 The advances in this field have improved diagnostic accuracy in human STS. 6 These alterations included chromosomal translocation, chromosomal numerical changes, oncogenic mutations, gene amplifications or deletions. 6, 7 Veterinary research in the genetic alterations in STS is vastly limited; however, future research in this field may provide objective diagnosis, improve prognostication as well as the development of possible targeted gene therapy.
Presently, the most used histological parameter to prognosticate canine STSs is the tumour grade, which is derived from a score calculated based on cellular differentiation, mitotic rate, and percentage of tumour necrosis. The application of these histologic criteria allows individual STS to be categorised into 3 grades (I-low grade, IIintermediate grade or III-high grade) . 3, [8] [9] [10] [11] Previous study has indicated that the grade is strongly predictive for local recurrence in marginally excised canine STSs.
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Multivariable analysis indicated that mitotic rate and percentage of tumour necrosis are the only statistically significant prognostic elements of the grading scheme. 3 The mitotic rate is predictive for distant metastasis, 3 survival time, 1, 3, 4 and local recurrence. 4 Tumour necrosis, is prognostic for survival time after surgery. 3 To date, no single histological criterion has been shown to be a consistent prognostic factor in local recurrence and other patient outcome assessments (such as distant metastasis, survival time and disease free interval) amongst studies. Histologically incomplete margin was significantly associated with decreased disease-free intervals and survival times. 12 There was also a trend of shorter survival time and higher local recurrence with larger tumour size; however, a statistical significance was not found. 4, 12 Comparatively, histological grading is the most important prognostic factor for STS in human patients. 9 Despite this, grade discrepancies are reported in 25%-34.6% human adult STS cases. 8, 10 In addition, the agreement for the diagnosis of non-visceral STS in humans was reported to be 78% between pathologists.
The objective of this study was to assess intra-and inter- For the intra-observer study, the cases were assessed by a single pathologist 6 months apart and slides were randomised between readings. For the inter-observer study, the complete case series was assessed by a single pathologist before being passed onto the next pathologist.
Initial evaluation targeted confirmation of the original diagnosis of STS (is it a STS?).
Cases where there was disagreement on the diagnosis of STS were excluded for the subsequent assessment of each canine STS histological parameter. 1 Criteria encompassed tumour differentiation, mitotic rate and percentage of tumour necrosis. 1 In concordance with the grading system, a correlating score was assigned for each criterion (Table 1) . 1 A final tumour grade was assigned based on the cumulative score from these 3 criteria (Table 2) . 1 The histologic subtype of the tumour was not assessed.
Statistical analyses were performed using a web-based programme (StatsToDo at www.statstodo.com). Intraclass correlation coefficient (ICC) and Fleiss's Kappa (κ) for the numerical and categorical values were calculated for the intra-(single observer) and interobserver agreement (3 observers). Interpretation of the ICC and the κ values is indicated in Table 3 . 
| Intra-observer study
Of 77 cases assessed by the pathologist 7 were considered to not be a STS. Of the cases that were considered STS, tumour grading between the 2 readings differed in 6 in 70 cases (8.6%). Of these 6 cases 2 had a different mitotic score and 4 cases had different necrosis scores, resulting in different final tumour grading. One case had a mitotic score difference of "1" and the other case had a difference of "2" between assessment, based on previously established assessment score. 1 The other 4 cases had a difference in necrosis score of "1". 1 All these 6 cases had the same differentiation score for both assessments.
Strong agreement was observed for the intra-observer assessment in necrosis score, mitotic score, total score and tumour grading (ICC between 0.78 and 0.91) ( Table 4 ). The intra-observer agreement for differentiation score was rated perfect (ICC = 1.00).
| Inter-observer study
Of the 77 samples previously diagnosed as STS 3 were unanimously assessed as non-STS by all the pathologists. The presumptive diagnosis for these cases included histiocytic sarcoma, haemangiosarcoma, The agreement for the diagnosis of STS, mitotic scores, necrosis scores and tumour grades were moderate among observers (κ between 0.43 and 0.60) ( Table 5 ). The differentiation score had poor agreement (κ = 0.11) and the total score for all histological criteria had poor agreement (κ = 0.20) among observers (Table 5) . If differentiation score was removed from the calculation of the total score, the inter-observer agreement improved to κ value of 0.44; this was an improvement of total score from fair to moderate agreement. Tumour grading has been regarded as the most important prognostic factor and best indicator of metastatic risk in human adult STS. 9 In veterinary medicine, STS tumour grading has been shown to be a predictive factor for local recurrence. 11, 14 The agreement on STS histological grading in this study was moderate (κ = 0.44), which was similar to that in human medicine (κ = 0.49). 8 Histological grading of STS can influence the recommendation of surgical margins, with margins of <1-3 cm being described as acceptable for low-grade STS. 15, 16 In comparison, other authors advised at least 3 cm peripheral margins and a deep margin of fascial plane for STS excision. been shown to be significantly associated with metastasis (regional and distant). 3, 18 In these studies, metastasis was reported to be as high as 44% of the grade III cases. 3, 18 This further emphasised the importance of consistent and accurate tumour grading, especially for prognostication of an individual patient.
Inconsistency in histological diagnosis and grading of canine STS also has a bearing on interpretation of published and future literature.
Currently, majority of the literature on canine STS investigated patient outcome based on retrospective information histological diagnosis of STS and the grading. Clearly, inconsistency in these histological assessment may raise question over the results produced by these studies. In addition, the inconsistency might also play a role in the variable results between studies, explaining why histological criteria, such as mitotic rate and degree of tumour necrosis, have been shown to be prognostic factors for various patient outcome assessment in some studies, but not in others. 1, 3, 11 Other factors that may result in variation in results between studies include different sample sizes, different methodology in case selection and patient outcome assessment.
In the intra-observer study, final tumour grading differed in 6 cases. In these cases, differences in mitotic and necrosis scores between the assessments resulted in final tumour grade disagreement. Interestingly, the differentiation score was consistent throughout these 6 cases, despite it being the most subjective criterion of the 3 in the inter-observer study (poor agreement). The marked difference in agreement of the differentiation score for intra-observer (perfect) and inter-observer (poor) could reflect the subjectivity in individual's interpretation of "degree of resemblance of sarcoma tissue to normal adult mesenchymal tissue".
Mitotic score and degree of necrosis have been established to be prognostic indicators for survival time, distant metastasis and local recurrence. 3, 4 These 2 criteria are more objective in comparison to the tumour differentiation. Despite the objectivity of these criteria, the agreement between observers was only moderate, in contrast to the strong intra-observer agreement. This could be due to variability in microscope field selection for the assessment as well as subjectivity in estimating the percentage of necrosis. In addition, the actual size of the field assessed for the mitotic scoring could vary based on different microscopes. 19 The variability in these criteria result in variability in the total cumulative score and resultant tumour grading.
Unfortunately, this variability represents the "real-life" situation in clinical setting as histological slides are assessed by different pathologists, at different laboratories and using different microscopes.
Agreement on tumour differentiation was poor among observers.
This was likely to be secondary to the subjective nature of this assessment. However, microscope field selection, again, could play a role in this. Interestingly, tumour differentiation score was perfect for the intra-observer study. This, along with strong to almost perfect agreement on other criteria, indicated consistency in singlepathologist evaluation in canine STS.
To minimise the undesired effect of inter-observer variability in the histological assessment of canine STS, recommendations have been made to minimise inconsistency among pathologists. beneficial. The incorporation of immunohistochemical assessment, especially the non-morphological, proliferative markers such as K i -67 counts and AgNOR assay, may improve the diagnostic specificity, and hence accuracy of prognostic advice on STS in dogs. 17, 20, 21 Further development in molecular genetics of canine STS and the use of automated mitosis detection may also provide consistent and accurate diagnosis. 6, 22 One of the limitations of this study is the lack of comparison of the results to the "real" results (such as the "real" tumour grading or the "real" mitotic rate). The intra-observer study showed strong to prefect agreement in all parameters assessed, indicating a strong consistency or precision. The inter-observer study showed moderate agreement, hence precision, in most parameters assessed. However, precision differs from accuracy; accuracy refers to the proximity of a measured value to the actual/"real" value whereas the term precision refers to the repeatability of a measurement. 23 As a result, a singlepathologist's histological assessment of canine STS can be precise and accurate at the same time or it can be precise but inaccurate.
Similarly, the moderate agreement and precision among pathologists did not necessary equate to moderate accuracy. The clinical application of this limitation is unknown as there is currently no test that can provide perfect accuracy in the histological assessment of canine STS.
Another limitation of the study is the small numbers of pathologists recruited. A previous study assessing reproducibility of histological grading in human STS had 15 pathologists as well as an additional separate panel involved in the study. 8 Despite the smaller number of pathologists involved in our study, the inter-observer agreement on histological grading was comparable (κ values of 0.49 and 0.44) to that of the human study. 8 
| CONCLUSION
Histological assessment of canine STS by an individual pathologist had high reproducibility. However, the agreement among pathologists for the diagnosis and grading of canine STS was moderate. Future studies are required to investigate further assessment criteria to improve the specificity of canine STS diagnosis and grading.
